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A 28-year-old man was admitted to the hospital 
due to strongly expressed dyspnoea, cough and pe-
ripheral oedema. The above symptoms started about 
4 weeks before the admission and had significantly 
increased in the last 2 days. In addition, he report-
ed the occurrence of papulopustular, itchy rash 
for several months. In 2013 and 2014, the patient 
underwent chemotherapy and radiotherapy for Hod-
gkin’s lymphoma (HL) which resulted in obtaining 
a remission. No other medical history was presented. 
At the admission, for a screening test, a transthoracic 
echocardiography was made which revealed a large 
amount of pericardial fluid and pathological mass 
in the heart. A  pericardiocentesis was performed 
promptly to decompress the cardiac tamponade and 
to collect material for histopathological examination. 
Unfortunately, immunohistochemistry did not allow 
to make a diagnosis. After the pericardial drainage, 
the patient’s condition was stabilized, enabling 
further diagnostic processes. Initially, we decided 
to perform a  full echocardiographic examination, 
that showed irregular, heterogeneous masses 
which were encompassing the base of the heart, 
filling the right ventricle and the majority of the right 
atrium. Subsequently, we utilized imaging studies 
to determine the size of the lesion and the extent 
of its infiltration. Computed tomography scan and 
magnetic resonance imaging of the chest revealed 
the presence of fluid in pleural cavities and pericar-
dial sac, as well as the distorted image of the heart 
due to advanced infiltration. The pathological mass 
was extending from upward and downward of the 
cardiac wall, penetrating the interventricular septum, 
and growing into the right heart cavities. The lesion 
adhered tightly to the anterior chest wall, causing the 
mass effect on the left atrium. Moreover, the tumour 
was covering and pressing on big vessels, such as 
lung trunk, the aorta, left carotid artery and subcla-
vian artery. In addition, numerous enlarged lymph 
nodes were observed in the mediastinum. Subclavi-
an and cervical lymph nodes were palpable during 
the physical examination. Regarding the history of 
HL, the lymph node biopsies were evaluated in the 
histopathological examination, which described 
findings typical to HL. Immediate standard treatment 
was started with adriamycin, bleomycin, vinblastine 
and dacarbazine. PET-CT scan, conducted after two 
treatment cycles, revealed numerous, enlarged, 
diseased lymph nodes, and the patient had been 
qualified for chemotherapy with brentuximab vedotin 
and bendamustin. After two treatment cycles, the 
PET-CT study was repeated. The image of nodal 
lesions corresponded to the significant metabolic 
and morphological regression, and significant reduc-
tion of cardiac lesions was described. The patient’s 
condition has normalized, all symptoms have disap-
peared and the physical capacity has returned. The 
patient continues haematological treatment.
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Figure 1. Legend
A – Echocardiography – parasternal short axis projection – pathological mass filling the right ventricle
B – Echocardiography – parasternal long axis projection – pathological mass filling the right ventricle
C – Echocardiography – untypical apical projection – preserved residual flow through the right ventricle
D – Magnetic resonance – pathological mass filling the right ventricle, passing through the free wall of the right ventricle, 
reaching to the wall of the chest
RV – right ventricle
LV – left ventricle
Tu – tumour
Discussion
HL metastases in the heart are described on the ba-
sis of sectional studies in approximately 25% of cases 
(1). Occasionally, the cardiac manifestation of HL in the 
form of arrhythmias, heart failure, cardiac tamponade, 
overtakes other symptoms (2). It should be noted, that 
the pericardial fluid does not have to result from HL 
metastases to the heart tissues. It may be associated 
with impaired flow caused by the blockage of lymphatic 
or/and venous drainage of pericardial fluid associated 
with neoplasmatic cells or the compression of enlarged 
lymph nodes (3). The existence of cardiac alterations 
in the course of HL may hinder the evaluation of late 
effects of treatment. Therefore, the prognosis should 
be determined on the basis of typical criteria (4).
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